2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow ASP1128: new trials by email Literature Review of ASP1128 trials Research Report on ASP1128
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery ASP1128, Placebo - Acute Kidney Injury (AKI) | Phase 2 | Completed | Astellas Pharma Inc | 351 | 2019-11-01 | 2024-12-04 |
| A Study of MA-0217 (ASP1128) in Healthy Adult Subjects and Healthy Elderly Subjects ASP1128, Placebo - Healthy Volunteers | Phase 1 | Completed | Astellas Pharma Europe B.V. | 102 | 2017-11-20 | 2024-11-18 |
Astellas Pharma Europe B.V. (1) · Astellas Pharma Inc (1)
United States (2)